Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Strobel

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
Medicine|March 10, 2020
Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant)Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, et al.
Cells|February 13, 2019
Systematic Generation of Patient-Derived Tumor Models in Pancreatic CancerKarl Roland Ehrenberg, Jianpeng Gao, Felix Oppel, et al.
EMBO Molecular Medicine|June 14, 2015
Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancyChristian Stoy, Aishwarya Sundaram, Marcos Rios Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2020
The Outcome of <i>Ex Vivo</i> TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic <i>In Vitro</i> Growth Capacity between T-Cell ClonesIsabel C Poschke, Jessica C Hassel, Aaron Rodriguez-Ehrenfried, et al.
Nature Cancer|September 7, 2023
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDACXu Zhou, Jingyu An, Roma Kurilov, et al.
Carcinogenesis|January 11, 2019
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patientsManuel Gentiluomo, Paula Puchalt García, Alice Alessandra Galeotti, et al.
Annals of Surgery|July 11, 2020
A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-scoreThomas Hank, Marta Sandini, Cristina R Ferrone, et al.
Molecular Metabolism|February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMichaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Medicine|March 10, 2020
Expanding pancreas donor pool by evaluation of unallocated organs after brain death: Study protocol clinical trial (SPIRIT Compliant)Yakup Kulu, Elias Khajeh, Omid Ghamarnejad, et al.
Cells|February 13, 2019
Systematic Generation of Patient-Derived Tumor Models in Pancreatic CancerKarl Roland Ehrenberg, Jianpeng Gao, Felix Oppel, et al.
EMBO Molecular Medicine|June 14, 2015
Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancyChristian Stoy, Aishwarya Sundaram, Marcos Rios Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2020
The Outcome of <i>Ex Vivo</i> TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic <i>In Vitro</i> Growth Capacity between T-Cell ClonesIsabel C Poschke, Jessica C Hassel, Aaron Rodriguez-Ehrenfried, et al.
Nature Cancer|September 7, 2023
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDACXu Zhou, Jingyu An, Roma Kurilov, et al.
Carcinogenesis|January 11, 2019
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patientsManuel Gentiluomo, Paula Puchalt García, Alice Alessandra Galeotti, et al.
Annals of Surgery|July 11, 2020
A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-scoreThomas Hank, Marta Sandini, Cristina R Ferrone, et al.
Molecular Metabolism|February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMichaela Schäfer, Christian U Oeing, Maria Rohm, et al.
Neuroendocrinology|August 3, 2021
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine TumorsCharlotte M Heidsma, Stijn van Roessel, Susan van Dieren, et al.
Gastroenterology|September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in MicePouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
Pageof 24